CLADELA
ActiveSummary
CLADELA has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€85,724) and a net result of €3,246, of which €4,094 non-recurring income. Equity is growing by about 6.6% per year across the filed financial years. Its solvency ranks better than 8% of 1,119 sector peers (NACE 18, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
16-04
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-09
Financial
Weakest financial yearnet €3,246 ▼40%
Net result drops to €3,246, the lowest in the series.
08-04
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
29-03
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
30-09
Financial
Highest result from 2019 to 2025net €12,577 ▲42%
Operating result €13,684, net result €12,577, both a record.
31-03
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-03
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
28-04
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
30-09
Financial
Liquidity more than quadruplescurrent ratio 1.58
Current ratio from 0.32 to 1.58; short-term debt falls from €195,102 to €39,730.
23-04
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
30-04
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
03-05
NBB filing
Annual accounts filed
financial year 2017 · micro format · 3 days late
2017
12-05
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 12 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 14 annual accounts filed, the latest 10 are here; all 14 are under Financials.
0 of 5 deeds read
About the unread acts
We know of 5 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.